THE INCIDENCE OF JAW OSTEONECROSIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH BISPHOSPHONATES

被引:0
|
作者
Kraj, M. [1 ]
Poglod, R. [1 ]
Maj, M. [1 ]
Owczarska, K. [1 ]
机构
[1] Inst Hematol & Transfus Med, Warsaw, Poland
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0671
引用
收藏
页码:269 / 269
页数:1
相关论文
共 50 条
  • [1] Osteonecrosis of the jaw in multiple myeloma patients receiving bisphosphonates
    Bilalis, A.
    Pouli, A.
    Konstantelos, D.
    Koropoulis, G.
    Stefanitsi, P.
    Sioni, A.
    Papanastasiou, K.
    Tsakanikas, S.
    Rapidis, A.
    Pamouktsoglou, P.
    Michaloudis, G.
    Stamatelou, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 255 - 255
  • [2] Higher Incidence of Osteonecrosis of the Jaw in Patients with Multiple Myeloma Treated with Zoledron
    de la Rubia, J.
    Bagan, J.
    Lopez, A.
    Garcia, I.
    Lopez, P.
    Ribas, P.
    Teruel, I.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S20 - S21
  • [3] Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
    Montefusco, Vittorio
    Gay, Francesca
    Spina, Francesco
    Miceli, Rosalba
    Maniezzo, Massimo
    Ambrosini, Maria Teresa
    Farina, Lucia
    Piva, Sheila
    Palumbo, Antonio
    Boccadoro, Mario
    Corradini, Paolo
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (11) : 2156 - 2162
  • [4] OSTEONECROSIS OF THE JAW IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH BISPHOSPHANATES
    Pavkovic, M.
    Petrushevska, G.
    Sotirova, T.
    Trpkovska-Terzieva, S.
    Karanfilski, O.
    Cevreska, L.
    Stankovic, S.
    Stojanovic, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 594 - 594
  • [5] Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: Definition and management of the risk related to zoledronic acid
    Cafro, Anna Maria
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (02): : 111 - 116
  • [6] Osteonecrosis of the myeloma patients treated with bisphosphonates
    Capalbo, Silvana
    Franzese, Maria Grazia
    Palumbo, Gaetano
    [J]. CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2007, 4 (01) : 43 - 47
  • [7] Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab
    Loyson, Tine
    Van Cann, Thomas
    Schoffski, Patrick
    Clement, Paul M.
    Bechter, Oliver
    Spriet, Isabel
    Coropciuc, Ruxandra
    Politis, Constantinus
    Vandeweyer, Raf O.
    Schoenaers, Joseph
    Dumez, Herlinde
    Berteloot, Patrick
    Neven, Patrick
    Nackaerts, Kristiaan
    Woei-A-Jin, Feng J. S. H.
    Punie, Kevin
    Wildiers, Hans
    Beuselinck, Benoit
    [J]. ACTA CLINICA BELGICA, 2018, 73 (02) : 100 - 109
  • [8] Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
    Kos, Marcin
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 319 - 324
  • [9] Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid
    Cetiner, Sedat
    Sucak, Gulsan Turkoz
    Kahraman, Sevil Altundag
    Aki, Sahika Zeynep
    Kocakahyaoglu, Benay
    Gultekin, Sibel Elif
    Cetiner, Mustafa
    Haznedar, Rauf
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (04) : 435 - 443
  • [10] Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid
    Sedat Cetiner
    Gulsan Turkoz Sucak
    Sevil Altundag Kahraman
    Sahika Zeynep Akı
    Benay Kocakahyaoglu
    Sibel Elif Gultekin
    Mustafa Cetiner
    Rauf Haznedar
    [J]. Journal of Bone and Mineral Metabolism, 2009, 27 : 435 - 443